These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26091578)

  • 1. Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.
    Hussner J; Begunk R; Boettcher K; Gliesche DG; Prestin K; Meyer Zu Schwabedissen HE
    Vascul Pharmacol; 2015 Sep; 72():25-34. PubMed ID: 26091578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices.
    Meyer Zu Schwabedissen HE; Begunk R; Hussner J; Juhnke BO; Gliesche D; Böttcher K; Sternberg K; Schmitz KP; Kroemer HK
    Mol Pharm; 2014 Mar; 11(3):665-72. PubMed ID: 24495124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
    Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
    Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
    Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
    Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin.
    Niessen J; Jedlitschky G; Grube M; Bien S; Schwertz H; Ohtsuki S; Kawakami H; Kamiie J; Oswald S; Starke K; Strobel U; Siegmund W; Rosskopf D; Greinacher A; Terasaki T; Kroemer HK
    Drug Metab Dispos; 2009 May; 37(5):1129-37. PubMed ID: 19237515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells.
    Giordano A; Romano S; Monaco M; Sorrentino A; Corcione N; Di Pace AL; Ferraro P; Nappo G; Polimeno M; Romano MF
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H135-42. PubMed ID: 22058159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of natural products as modulators of OATP2B1 using LC-MS/MS to quantify OATP-mediated uptake.
    Wen F; Shi M; Bian J; Zhang H; Gui C
    Pharm Biol; 2016; 54(2):293-302. PubMed ID: 25858254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression.
    Steinfeld DS; Liu AP; Hsu SH; Chan YF; Stankus JJ; Pacetti SD; Tai JT
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):179-86. PubMed ID: 22561362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells.
    Strohbach A; Begunk R; Petersen S; Felix SB; Sternberg K; Busch R
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26805825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration.
    Lavigne MC; Grimsby JL; Eppihimer MJ
    J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in
    Kinzi J; Hussner J; Seibert I; Vythilingam M; Vonwyl C; Gherardi C; Detampel P; Schwardt O; Ricklin D; Meyer Zu Schwabedissen HE
    Drug Metab Dispos; 2024 Aug; 52(9):957-965. PubMed ID: 39038952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in vitro.
    Sternberg K; Gratz M; Koeck K; Mostertz J; Begunk R; Loebler M; Semmling B; Seidlitz A; Hildebrandt P; Homuth G; Grabow N; Tuemmler C; Weitschies W; Schmitz KP; Kroemer HK
    J Biomed Mater Res B Appl Biomater; 2012 Jan; 100(1):41-50. PubMed ID: 22114061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart.
    Grube M; Köck K; Oswald S; Draber K; Meissner K; Eckel L; Böhm M; Felix SB; Vogelgesang S; Jedlitschky G; Siegmund W; Warzok R; Kroemer HK
    Clin Pharmacol Ther; 2006 Dec; 80(6):607-20. PubMed ID: 17178262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
    Zhu S; Viswambharan H; Gajanayake T; Ming XF; Yang Z
    BMC Cardiovasc Disord; 2005 Jul; 5():22. PubMed ID: 16018822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.